Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2018, Vol. 23 ›› Issue (5): 531-535.doi: 10.12092/j.issn.1009-2501.2018.05.008

Previous Articles     Next Articles

Macrophage migration inhibitory factor protects H9c2 cardiac myocytes against hypoxia/reoxygenation injury through regulation of autophagy

LI Jinyu1, HUANG Danmei 2, ZHANG Yanmei 2, SHI Ganggang 2, WANG Bin 2   

  1. 1 Drug Clinical Trial Institution, the Second Affiliated Hospital, 2 Department of Pharmacology,Shantou University Medical College, Shantou 515041, Guangdong, China
  • Received:2017-10-20 Revised:2017-12-30 Online:2018-05-26 Published:2018-05-16

Abstract:

AIM: To investigate the effects of macrophage migration inhibitory factor (MIF) on autophagy of H9c2 cardiac myocytes during hypoxia/reoxygenation (H/R) injury so as to explore the molecular mechanism. METHODS: The MIF mRNA-targeting siRNA was transfected to H9c2 cardiac myocytes. The H/R models of H9c2 cardiac myocytes were established. The autophagy inhibitor 3-methyladenine (3-MA) was added.The levels of MIF, LC3, Cleaved caspase-3 and mTOR protein expression in H9c2 cardiac myocytes were detected by Western blot. RESULTS: MIF siRNA transfection inhibited H/R-induced autophagy. The inhibitor of autophagy 3-MA suppressed H/R-induced autophagy and decreased apoptosis. MIF knockdown increased the expression of p-mTOR during H/R. CONCLUSION: MIF inhibits autophagy in H9c2 cardiomyocytes subjected to H/R, which is related to active mTOR protein.

Key words: macrophage migration inhibitory factor, hypoxia/reoxygenation, H9c2 cardiac myocyte, autophagy, apoptosis

CLC Number: